OVERVIEW

The 16th Annual Women and Ischemic Heart Disease Symposium will explore sex and gender-specific issues in ischemia with no obstructive CAD (INOCA), inclusion of women in cardiovascular disease leadership, management of chest pain and ischemic heart disease in women, COVID and Long Hauler Cardiac Conditions including postural orthostatic tacycardia syndrome (POTS) in women, menopause and ovarian aging in cardiovascular disease, Cardio-Obstetrics including Preeclampsia, and new approaches and therapies for weight management. Attendees are also invited to attend an optional panel discussion with all the speakers towards the end of the conference. The purpose of this conference is to close the knowledge gaps of physicians and allied healthcare professionals regarding gender- and sex-specific differences in cardiovascular disease, the impact these differences have on treatment options, and the importance of identifying women at risk for cardiovascular disease, by utilizing the most current evidence-based treatment strategies for optimizing patient-centered care.

TARGET AUDIENCE

Specialties - Cardiology, Emergency Medicine, Endocrinology & Metabolism, Family / General Medicine, Internal Medicine, Preventive Medicine

OBJECTIVES

1. Identify the social determinants that can influence women’s health to more effectively communicate with patients about health-related conditions and behaviors
2. Apply best practices in screening young women for heart disease and managing women with heart disease and diabetes
3. Explore sex differences in virtual medicine, including remote monitoring, adherence, and symptomatic conditions

ACCREDITATION

Cedars-Sinai Medical Center designates this Live Activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 For more information please visit the official event page.